Homocysteine levels in patients with coronary slow flow phenomenon: A meta-analysis

• Published in: PloS one Vol. 18; no. 7; p. e0288036
• Main Authors: Yu, Hong, Wang, Bei-Bei, Zhao, Meng, Feng, Feng, Li, Hua-Dong
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 07.07.2023
• Subjects: Age; Analysis; Angiography; Biology and Life Sciences; Body mass index; Cardiac patients; Cardiovascular disease; Care and treatment; Confounding (Statistics); Coronary Angiography; Coronary vessels; Correlation; Free radicals; Health aspects; Heart attacks; Heterogeneity; Homocysteine; Humans; Medical imaging; Medicine and Health Sciences; Meta-analysis; Myocardial Infarction; Nitric oxide; No-Reflow Phenomenon - diagnostic imaging; Oxidative stress; Physical Sciences; Research and Analysis Methods; Sensitivity analysis; Subgroups; Thrombolysis; Thrombolytic drugs; Veins & arteries; China
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0288036

With the development of coronary angiography, more and more attention has been paid to coronary slow flow phenomenon (CSFP). Recent studies have found that the correlation between homocysteine (Hcy) levels and CSFP was contradictory, so we conducted this meta-analysis to investigate the correlation. By March 2022, studies that meet the research requirements were identified by searching multiple databases including Embase, Web of Science, and PubMed. We included studies evaluating the correlation between Hcy levels and CSFP. Random or fixed effect meta-analyses were performed according to heterogeneity among included studies. A leave-out method and subgroup analyses were conducted to determine the source of heterogeneity. Thirteen studies involving 625 CSFP and 550 subjects were included. After pooling data from each study, Hcy levels were higher in the CSFP groups (standard mean difference [SMD], 1.45; 95% CI, 0.94 to 1.96, P < .00001) than in the control group. In the meta-analysis, there was significant heterogeneity (I2 = 93%), which was further explored through leave-out method and and subgroup analyses. Specifically, pooling data from studies with a mean thrombolysis in myocardial infarction (TIMI) frame count ≥ 46 (SMD, 1.31; 95% CI, 1.00 to 1.63, P < .00001) resulted in no heterogeneity (0%), indicating that the TIMI frame count ≥ 46 was the source of heterogeneity. Our study found that elevated Hcy levels are strongly associated with CSFP. More importantly, the association was stronger in CSFP patients with mean TIMI frame count ≥ 46.